First Eagle Investment Management
PCRX icon

First Eagle Investment Management’s Pacira BioSciences PCRX Stock Holding History

First Eagle Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-103,081
Closed -$3.48M – 422
2023
Q4 		$3.48M Sell
103,081
-104,551
-50% -$3.06M 0.01% 287
2023
Q3 		$6.37M Sell
207,632
-36,640
-15% -$1.32M 0.02% 184
2023
Q2 		$9.79M Buy
244,272
+67,847
+38% +$2.81M 0.03% 98
2023
Q1 		$7.2M Buy
176,425
+93,412
+113% +$3.72M 0.02% 105
2022
Q4 		$3.21M Buy
83,013
+4,482
+6% +$218K 0.01% 194
2022
Q3 		$4.18M Buy
78,531
+8,706
+12% +$484K 0.01% 97
2022
Q2 		$4.07M Buy
69,825
+22,104
+46% +$1.45M 0.01% 89
2022
Q1 		$3.64M Buy
47,721
+22,889
+92% +$1.53M 0.01% 87
2021
Q4 		$1.49M Buy
+24,832
New +$1.37M ﹤0.01% 97

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $34.9B AUM 18.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return